These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 23964070)
1. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070 [TBL] [Abstract][Full Text] [Related]
2. Lessons from mouse models of high-fat diet-induced NAFLD. Nakamura A; Terauchi Y Int J Mol Sci; 2013 Oct; 14(11):21240-57. PubMed ID: 24284392 [TBL] [Abstract][Full Text] [Related]
3. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599 [TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577 [TBL] [Abstract][Full Text] [Related]
5. A mouse model for nonalcoholic steatohepatitis. Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824 [TBL] [Abstract][Full Text] [Related]
6. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280 [TBL] [Abstract][Full Text] [Related]